Technical Analysis for OVIT - Oncovista Innovative Therapies I

Grade Last Price % Change Price Change
grade F 0.0161 -19.50% -0.0039
OVIT closed down 19.5 percent on Thursday, February 20, 2020, on 3.16 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical OVIT trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 50 DMA Bearish -19.50%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -19.50%
Narrow Range Bar Range Contraction -19.50%
Wide Bands Range Expansion -19.50%
Older signals for OVIT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

OncoVista Innovative Therapies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted anticancer therapies by utilizing tumor-associated biomarkers. The Company's product pipeline consists of advanced (Phase II) and early (Phase I) clinical-stage compounds, late preclinical drug candidates and early preclinical leads. The Company's therapeutic strategy is based on targeting the patient's tumors with treatments that will deliver drugs selectively based upon specific biochemical characteristics of the cancer cells comprising the tumor. The Company's products include: Cordycepin (OVI-123) and L-Nucleoside Conjugates (OVI-117). Cordycepin depends upon the presence of a DNA polymerase, known as terminal deoxynucleotidyl transferase (TdT), for its therapeutic activity. OVI-117 is a thymidylate synthase (TS) inhibitor with pharmacological properties, which results in a retention of efficacy and a reduction of toxicity.
Medicine Biotechnology Branches Of Biology Cancer Biopharmaceutical Clinical Medicine Tumor Biomarkers Chemical Pathology Cordycepin Polymerase

Is OVIT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.0625
52 Week Low 0.0065
Average Volume 24,666
200-Day Moving Average 0.0285
50-Day Moving Average 0.0212
20-Day Moving Average 0.0193
10-Day Moving Average 0.0191
Average True Range 0.0063
ADX 22.92
+DI 34.8917
-DI 21.3227
Chandelier Exit (Long, 3 ATRs ) 0.0090
Chandelier Exit (Short, 3 ATRs ) 0.0339
Upper Bollinger Band 0.0282
Lower Bollinger Band 0.0104
Percent B (%b) 0.32
BandWidth 92.2280
MACD Line -0.0006
MACD Signal Line -0.0007
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0265
Resistance 3 (R3) 0.0276 0.0252 0.0247
Resistance 2 (R2) 0.0252 0.0226 0.0247 0.0241
Resistance 1 (R1) 0.0207 0.0210 0.0230 0.0196 0.0236
Pivot Point 0.0183 0.0183 0.0195 0.0178 0.0183
Support 1 (S1) 0.0138 0.0157 0.0161 0.0127 0.0086
Support 2 (S2) 0.0114 0.0141 0.0109 0.0081
Support 3 (S3) 0.0069 0.0114 0.0075
Support 4 (S4) 0.0058